NL-OMON53586
Completed
Not Applicable
The feasibility and potential efficacy of adding Tobacco Treatment using EMDR (ToTEM) to a regular smoking cessation program;A pilot randomized controlled trail in inpatient daily smokers with a substance use disorder - ToTEM
IrisZorg0 sites1 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- IrisZorg
- Enrollment
- 1
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Diagnosis of Tobacco Use Disorder according to the DSM\-5 (American
- •Psychiatric Association, 2013\) criteria.
- •\- Age \>\= 18 years.
- •\- Good Dutch language proficiency (based on clinical judgement).
- •\- Smoking, on average, \>\= 10 cigarettes per day pre\-admission.
- •\- A score of at least 5 on a scale from 0 to 10, for motivation and
- •self\-efficacy
- •\- A planned inpatient stay of \>\= 4 weeks.
- •\- Written informed consent.
Exclusion Criteria
- •\- Serious therapy interfering behavior or symptoms that also interfere with
- •TAU, based on clinical judgement (e. g. psychiatric or medical crisis that
- •requires immediate intervention).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The evaluation of the influence of the use of total blood volume measurement during dialysis on the incidence of intradialytic hypotension associated eventsNL-OMON55297HagaZiekenhuis59
Completed
Not Applicable
Beat-It: A pilot study on the practicality and effectiveness of a m-health application in improving emotion regulation in adolescents with externalizing disorder.ADHDConduct Disorder10021563NL-OMON40187Yulius26
Completed
Not Applicable
Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure DeviceAandoeningen aan de hartklepCardiac diseaseVascular intervention1001928010003184NL-OMON42594Essential Medical Inc.35
Completed
Not Applicable
A prospective, multi-centre study investigating the incidence and prognosis of relapses, pseudo-relapses and other causes of (sub)acute neurological symptoms in patients with relapsing-remitting multiple sclerosis.NL-OMON55562Sint Elisabeth Ziekenhuis125
Completed
Phase 4
An Open-Label Study of the Safety and Efficacy of ReFacto AF in Previously Untreated Patients in Usual Care Settingsfactor VIII deficiencyHemophilia A1006447710005330NL-OMON39506Pfizer1